Rounded Base Breakout Brewing in a Fundamentally Resilient Pharma Major

🔹 Technical Structure (Confluence-Based View) 1. Elliott Wave Structure The strong rally into mid-2024 completed a higher-degree Wave (3). The subsequent decline and long consolidation have unfolded as a corrective Wave (4), taking the form of a rounded / cup-like structure rather than a sharp zigzag. Price now approaching the upper boundary of this structure suggests early development of Wave (5), provided a clean weekly breakout is achieved. 2. MACD Momentum Insight Weekly MACD shows bullish divergence during the base formation: Price made marginally lower or equal lows, MACD histogram printed higher lows and flattened near the zero line. This indicates loss of bearish momentum and accumulation during the corrective phase, often seen before trend resumption in pharma leaders. 3. AVWAP Role AVWAP anchored from the 2024 swing high aligns closely with the ₹1,270–1,280 resistance zone. Price acceptance above this AVWAP would confirm a change in control from sellers to buyers. Once reclaimed, this AVWAP zone is likely to act as a strong demand area on any retest. 🔹 Fundamental Strength (Why the Pattern Is Trustworthy) Aurobindo Pharma benefits from diversified revenue streams across APIs, formulations, and regulated markets. The company has demonstrated consistent operating cash flows and improving margin stability. Strong presence in export markets and scale-driven efficiencies support earnings durability, making the stock suitable for longer-cycle moves rather than short-term speculation.